Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease

References

• Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995; 26:131–6.
   PubMed Web of Science ®Google Scholar
• El Ramahi KM, Al Rayes HM. Systemic lupus erythematosus associated with moyamoya syndrome. Lupus 2000;9:632–6.
   PubMed Web of Science ®Google Scholar
• Gaba RC, Shah RP, Muskovitz AA, Guzman G, Michals EA. Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome. J Clin Neurosci 2008;15:1395–8.
   PubMed Web of Science ®Google Scholar
• Hung P-C, Wang H-S, Wong AM-C, et al. Moyamoya syndrome in a child with Noonan syndrome. Pediatr Neurol 2011;45:129–31.
   PubMed Web of Science ®Google Scholar
• Kainth DS, Chaudhry SA, Kainth HS, Suri FK, Qureshi AI. Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease. Neurosurgery 2013;72:210–15.
   PubMed Web of Science ®Google Scholar
• Moftakhar P, Smith ER, Choulakian A, Scott RM, Danielpour M. Moyamoya disease in children with congenital dwarfing conditions. Pediatr Neurosurg 2010;46:373–80.
   PubMed Web of Science ®Google Scholar
• Moritani T, Numaguchi Y, Lemer NB, et al. Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography. Clin Imaging 1999;28:173–86.
   Web of Science ®Google Scholar
• Switzer JA, Hess DC, Nichols FT, et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006;5:501–12.
   PubMed Web of Science ®Google Scholar
• Agarwalla PK, Stapleton CJ, Phillips MT, Walcott BP, Venteicher AS, Ogilvy CS. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya. J Neurosurg 2014;121:1394–400.
   PubMed Web of Science ®Google Scholar
• Bemrich-Stolz CJ, Griessenauer C, Hilliard L, Howard TH, DeBaun MR, Johnston JM. Encephaloduroarteriosynangiosis (EDAS) for patients with sickle cell disease. Blood 2013;122:999.
   PubMed Web of Science ®Google Scholar
• Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 2003;29:124–30.
   PubMed Web of Science ®Google Scholar
• Hankinson TC, Bohman L-E, Heyer G, et al. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J Neurosurg Pediatr 2008;1:211–16.
   PubMed Web of Science ®Google Scholar
• Vernet O, Montes JL, O’Gorman AM, Baruchel S, Farmer JP. Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol 1996;14:226–30.
   PubMed Web of Science ®Google Scholar
• Matsushima Y, Fukai N, Tanaka K, et al. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol 1981;15:313–20.
   PubMedGoogle Scholar
• Adelson PD, Scott RM. Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg 1995;23:26–33.
   PubMed Web of Science ®Google Scholar
• Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100:142–9.
   PubMed Web of Science ®Google Scholar
• Griessenauer CJ, Lebensburger JD, Chua MH, et al. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. J Neurosurg Pediatr 2015;16:64–73.
   PubMed Web of Science ®Google Scholar
• Hall EM, Leonard J, Smith JL, et al. Reduction in overt and silent stroke recurrence rate following cerebral revascularization surgery in children with sickle cell disease and severe cerebral vasculopathy. Pediatr Blood Cancer 2016;14:1526–31.
   Google Scholar
• Kennedy BC, McDowell MM, Yang PH, et al. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases. Neurosurg Focus 2014;36:E12.
   PubMed Web of Science ®Google Scholar
• Lei Y, Li Y-J, Guo Q-H, et al. Postoperative executive function in adult moyamoya disease: a preliminary study of its functional anatomy and behavioral correlates. J Neurosurg 2016;126:527–36.
   PubMed Web of Science ®Google Scholar
• Berkelhammer LD, Williamson AL, Sanford SD, et al. Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature. Child Neuropsychol 2007;13:120–31.
   PubMed Web of Science ®Google Scholar
• Wang WC. Central nervous system complications of sickle cell disease in children: an overview. Child Neuropsychol 2007;13:103–19.
   PubMed Web of Science ®Google Scholar